Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

TTK HEALTHCARE LTD.

NSE : TTKHLTCAREBSE : 507747ISIN CODE : INE910C01018Industry : Pharmaceuticals & DrugsHouse : TTK

BSE1516.80-33.7 (-2.17 %)

PREV CLOSE ( ) 1550.50

OPEN PRICE ( ) 1540.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 591

TODAY'S LOW / HIGH ( )1510.55 1564.45

52 WK LOW / HIGH ( )1117.05 1725.85

NSE1515.65-34.4 (-2.22 %)

PREV CLOSE( ) 1550.05

OPEN PRICE ( ) 1500.55

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1515.65 (1)

VOLUME 4393

TODAY'S LOW / HIGH( ) 1500.55 1547.90

52 WK LOW / HIGH ( )1101.2 1744

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1958

Management Info

T T Raghunathan - Chairman - Managing Director

Registered Office

Address No 6 , Cathedral Road, , ,
Chennai,
Tamil Nadu-600086

Phone 044-28116106-08

Email info@ttkhealthcare.com

Website www.ttkhealthcare.com

Registrars Details

Data Software Research Co Pvt Ltd

19 Pycroft Garden Road,Off Haddows Road,Nungambakkam,Chennai

Listing : BSE, NSE, MCX

NEWS

22Dec Ttk Healthcare informs about clarifica
With acknowledge receipt of communication L/SURV/ONL/PV/NP/2023-2024/497..

21Nov Ttk Healthcare informs about loss of s
Ttk Healthcare has informed that it enclosed Certificate under Reg 39(3)..

03Nov Ttk Healthcare submits unaudited finan
Ttk Healthcare has informed that it enclosed the Unaudited Financial Res..

17Aug TTK Healthcare informs about details o
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, TTK Healt..

26May TTK Healthcare informs about secretari
In accordance with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th Febr..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	128.95	6397.15
Gross Profit	177	616.370000000001
Operating Profit	212.4	796.820000000001
Net Sales	1838.47	7251.1

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Ajanta Pharma (BSE) 2377.00 (6.44%)	M.Cap ( in Cr)29930.39
Alkem Laboratories (BSE) 4899.45 (2.36%)	M.Cap ( in Cr)58580.27
Astrazeneca Pharma I (BSE) 5424.45 (1.70%)	M.Cap ( in Cr)13561.13
Dr. Reddy's Lab (BSE) 6349.95 (0.98%)	M.Cap ( in Cr)105928.76
Torrent Pharma (BSE) 2732.60 (2.20%)	M.Cap ( in Cr)92483.60

Shareholding Pattern

	PROMOTERS	74.56%
	NON-INSTITUTION	22.45%
	FII	1.85%
	FI/BANKS/INSURANCE	0.01%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

TTK HEALTHCARE LTD.